Seven papers
by Melvin E Andersen
published in 2016
- MM Miller, RA Alyea, C LeSommer, DL Doheny, SM Rowley, KM Childs, P Balbuena, SM Ross, J Dong, B Sun, RA Clewell, and ME Andersen. Editor's Highlight: Development of an In vitro Assay Measuring Uterine-Specific Estrogenic Responses for Use in Chemical Safety Assessment. Toxicol Sci 154 (1) : 162-173 (Nov 7, 2016). [abstract] [pubmed]
- G Song, CR Peeples, M Yoon, H Wu, MA Verner, ME Andersen, HJ Clewell, and MP Longnecker. Pharmacokinetic bias analysis of the epidemiological associations between serum polybrominated diphenyl ether (BDE-47) and timing of menarche. Environ Res 150 : 541-548 (Oct 16, 2016). [abstract] [pubmed]
- J Zhu, H Wang, F Chen, J Fu, Y Xu, Y Hou, HH Kou, C Zhai, MB Nelson, Q Zhang, ME Andersen, and J Pi. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy. Free Radic Biol Med 99 : 544-556 (Oct 12, 2016). [abstract] [pubmed]
- V Soldatow, RC Peffer, OJ Trask, DE Cowie, ME Andersen, E LeCluyse, and C Deisenroth. Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation. Toxicol In Vitro 36 : 224-237 (Oct 12, 2016). [abstract] [pubmed]
- JM Pedersen, YS Shim, V Hans, MB Phillips, JM Macdonald, G Walker, ME Andersen, HJ Clewell, and M Yoon. Fluid Dynamic Modeling to Support the Development of Flow-Based Hepatocyte Culture Systems for Metabolism Studies. Front Bioeng Biotechnol 4 : 72 (Sep 30, 2016). [abstract] [pubmed]
- RA Clewell, and ME Andersen. Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitro. Mutagenesis 31 (3) : 333-40 (May 4, 2016). [abstract] [pubmed]
- RA Clewell, PD McMullen, Y Adeleye, PL Carmichael, and ME Andersen. Pathway Based Toxicology and Fit-for-Purpose Assays. Adv Exp Med Biol 856 : 205-230 (Jan 1, 2016). [abstract] [pubmed]